Genfit S.A. (GNFTF)
USD 5.55
(0.0%)
USD 5.55
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -28.05 Million EUR | 33.17% |
| 2022 | -33.37 Million USD | -198.05% |
| 2021 | 34.04 Million USD | 133.83% |
| 2020 | -89.2 Million USD | -57.59% |
| 2019 | -63.85 Million USD | 25.99% |
| 2018 | -86.28 Million USD | -16.09% |
| 2017 | -74.31 Million USD | -79.39% |
| 2016 | -35.28 Million USD | -81.59% |
| 2015 | -17.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - EUR | 33.17% |
| 2023 Q2 | -22.9 Million USD | -120.58% |
| 2023 Q1 | -10.38 Million EUR | 33.7% |
| 2023 Q3 | 2.81 Million EUR | 112.3% |
| 2023 Q4 | 14.26 Million EUR | 406.21% |
| 2022 Q4 | -15.66 Million USD | -159.76% |
| 2022 Q3 | -6.02 Million EUR | 63.58% |
| 2022 Q2 | -16.55 Million USD | 0.0% |
| 2022 FY | - USD | -198.05% |
| 2021 Q2 | -35.53 Million USD | 0.0% |
| 2021 FY | - USD | 133.83% |
| 2021 Q4 | 68.1 Million USD | 0.0% |
| 2020 Q2 | -59.21 Million USD | 0.0% |
| 2020 FY | - USD | -57.59% |
| 2020 Q4 | -35.55 Million USD | 0.0% |
| 2019 FY | - USD | 25.99% |
| 2019 Q2 | -54.69 Million USD | 0.0% |
| 2019 Q4 | -9.17 Million USD | 0.0% |
| 2018 FY | - USD | -16.09% |
| 2017 FY | - USD | -79.39% |
| 2016 FY | - USD | -81.59% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 60.512% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -373.122% |
| SQZ Biotechnologies Company | -64.14 Million USD | 56.267% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -61.491% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 129.829% |
| Mesoblast Limited | -62.38 Million USD | 55.039% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1726.179% |
| Genus plc | 73.7 Million USD | 138.061% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -324.275% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -690.838% |
| Marizyme, Inc. | -34.28 Million USD | 18.174% |
| ContraFect Corporation | -64.99 Million USD | 56.844% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -219.779% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -519.748% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1901.059% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -960.751% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -1107.107% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -5314.77% |
| Accustem Sciences Inc. | -3.74 Million USD | -648.742% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 41.835% |
| EV Biologics, Inc. | -1.26 Million USD | -2113.739% |
| Q BioMed Inc. | -617.62 Thousand USD | -4441.731% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 885.302% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -4335.6% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -1127.889% |
| Biomind Labs Inc. | -1.03 Million USD | -2611.423% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 384.003% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -291.704% |
| Skye Bioscience, Inc. | -13.54 Million USD | -107.056% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -1785.893% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -112104.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -622.16% |
| IMV Inc. | -35.52 Million USD | 21.035% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -76.758% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -1021.16% |
| GB Sciences, Inc. | -1.41 Million USD | -1875.583% |
| Alpha Cognition Inc. | -9.7 Million USD | -189.019% |
| HST Global, Inc. | -5303.00 USD | -528864.737% |
| CSL Limited | 4.78 Billion USD | 100.586% |
| Halberd Corporation | -74.27 Thousand USD | -37664.375% |
| Enzolytics Inc. | -2.12 Million USD | -1221.895% |
| Resverlogix Corp. | -11.74 Million USD | -138.895% |
| Affymax, Inc. | -14.29 Million USD | -96.229% |
| SYBLEU INC | -141.57 Thousand USD | -19714.086% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -815.797% |
| argenx SE | -216.02 Million USD | 87.015% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 49.311% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 2404.93% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -1771.432% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 7504.367% |
| AVAX Technologies, Inc. | -6.11 Million USD | -358.901% |
| Zenith Capital Corp. | -8.6 Million USD | -225.947% |
| Genscript Biotech Corporation | -248.71 Million USD | 88.722% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -160918.311% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -1046.595% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -15835.863% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 29.23% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -869.842% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -2580.94% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 417277.275% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -1502.915% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -1360.297% |
| BioStem Technologies, Inc. | -7.55 Million USD | -271.357% |
| ONE Bio Corp. | 13.61 Million USD | 306.06% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -15390.259% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -1263.685% |
| Agentix Corp. | -1.37 Million USD | -1944.897% |
| LadRx Corporation | 412.28 Thousand USD | 6903.822% |
| Cell Source, Inc. | -4.27 Million USD | -556.544% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -7538.724% |
| Regen BioPharma, Inc. | 1.46 Million USD | 2013.495% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -2893.866% |
| NovAccess Global Inc. | -1.03 Million USD | -2610.773% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 416.824% |
| Itoco Inc. | -1.86 Million USD | -1400.86% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -7289.231% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -2413.53% |
| Kadimastem Ltd | -2.62 Million USD | -968.862% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -11629.458% |
| CytoDyn Inc. | -18.02 Million USD | -55.588% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -35394.565% |
| Mobile Lads Corp. | -2.24 Million USD | -1151.629% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -229280.98% |
| Qrons Inc. | -40.08 Thousand USD | -69885.779% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -5675.637% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 5418.401% |
| Rebus Holdings, Inc. | -951 Thousand USD | -2849.632% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -2541.312% |
| International Stem Cell Corporation | 202 Thousand USD | 13986.634% |
| Bioxytran, Inc. | -3.82 Million USD | -634.291% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -53188.374% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -1039.39% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 21.796% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -62235.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -924.507% |
| Neutra Corp. | -181.24 Thousand USD | -15376.67% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -39.149% |
| PureTech Health plc | -11.62 Million USD | -141.257% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -39.158% |
| IXICO plc | -707 Thousand USD | -3867.61% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -265.01% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 41.979% |
| CSL Limited | 4.73 Billion USD | 100.593% |
| Cellectis S.A. | -92.63 Million USD | 69.719% |